Oncotool for Cancer Medications

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

August 13, 2022

Study Completion Date

November 4, 2022

Conditions
CancerCancer, Treatment-RelatedMedication AdherenceCommunicationTyrosine Kinase Inhibitor
Interventions
BEHAVIORAL

Oncotool Intervention (symptom reporting + TKI education)

OncoTool is a website intended to improve self-management practices for helping cancer patients cope with side effects and improve health-related quality of life. OncoTool provides symptom education and management for dealing with the numerous physical and mental side effects associated with TKIs (e.g., fatigue, nausea, skin toxicity). OncoTool is a website designed to improve TKI adherence by improving quality of life and TKI associated symptom burden, as well as providing a portal for provider-patient communication via a bi-weekly health questionnaire. Both intervention and active comparator conditions are administered to participants for 8 weeks.

BEHAVIORAL

Oncotool Control (health information)

OncoTool is a health promotion website with health education on subjects like nutrition and exercise specific to cancer patients, as well as general advice on lifestyle choices and prevention. The Oncotool control has similar TKI education content as the experimental content but without the side effect education or physician notification. Both intervention and active comparator conditions are administered to participants for 8 weeks.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03952312 - Oncotool for Cancer Medications | Biotech Hunter | Biotech Hunter